Showing results (231-240 of 296) with videos related to

Sort By:
Pageof 30
Cell Reports|August 19, 2014
Nontranscriptional role of Hif-1α in activation of γ-secretase and notch signaling in breast cancerJennifer C Villa, Danica Chiu, Alissa H Brandes, et al.
Radiology|May 9, 2002
Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CTMatthijs Oudkerk, Carl G Torres, Bin Song, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapiesMagdalena Skubal, Benedict Mc Larney, Ngan Bao Phung, et al.
Blood|April 20, 2010
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemiaPeter G Maslak, Tao Dao, Lee M Krug, et al.
Blood|August 1, 2002
Targeted alpha particle immunotherapy for myeloid leukemiaJoseph G Jurcic, Steven M Larson, George Sgouros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural MesotheliomaMarjorie G Zauderer, Anne S Tsao, Tao Dao, et al.
Cancer Immunology Research|June 28, 2023
Host Interactions with Engineered T-cell MicropharmaciesChristopher M Bourne, Patrick Wallisch, Megan M Dacek, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2010
Imaging primary lung cancers in mice to study radiation biologyDavid G Kirsch, Jan Grimm, Alexander R Guimaraes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2010
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemiaTodd L Rosenblat, Michael R McDevitt, Deborah A Mulford, et al.
JCI Insight|March 9, 2022
A TCR mimic monoclonal antibody reactive with the "public" phospho-neoantigen pIRS2/HLA-A*02:01 complexTao Dao, Sung Soo Mun, Zaki Molvi, et al.
Pageof 30